Clinical Trials Browser

Phase 3 × Has results × Muscular Atrophy × Clear all

NCT01355497 2020-11-09

Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum

Phase 3 Completed

330 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Muscular Atrophy

NCT01355484 2016-03-03

Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Completed

321 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Muscular Atrophy